MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE 1 in the 9q22 thyroid cancer risk locus

86Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

A locus on chromosome 9q22 harbors a SNP (rs965513) firmly associated with risk of papillary thyroid carcinoma (PTC). The locus also comprises the forkhead box E1 (FOXE1) gene, which is implicated in thyroid development, and a long noncoding RNA (lncRNA) gene, papillary thyroid cancer susceptibility candidate 2 (PTCSC2). How these might interact is not known. Here we report that PTCSC2 binds myosin-9 (MYH9). In a bidirectional promoter shared by FOXE1 and PTCSC2, MYH9 inhibits the promoter activity in both directions. This inhibition can be reversed by PTCSC2, which acts as a suppressor. RNA knockdown of FOXE1 in primary thyroid cells profoundly interferes with the p53 pathway. We propose that the interaction between the lncRNA, its binding protein MYH9, and the coding gene FOXE1 underlies the predisposition to PTC triggered by rs965513.

Cite

CITATION STYLE

APA

Wang, Y., He, H., Li, W., Phay, J., Shen, R., Yu, L., … De La Chapelle, A. (2017). MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE 1 in the 9q22 thyroid cancer risk locus. Proceedings of the National Academy of Sciences of the United States of America, 114(3), 474–479. https://doi.org/10.1073/pnas.1619917114

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free